Childrens Hospital Of Koblenz
- Address
- lock Available on a paid plan
Neoplasms in Pediatric Hematology and Oncology
At Childrens Hospital Of Koblenz, clinical research is centered on neoplasms in children and adolescents, with a strong focus on improving outcomes in rare and challenging cancers. The studies explore new ways to strengthen treatment effectiveness, support event-free survival, and refine care for young patients with cancer.
- Malignant Extracranial Germ Cell Tumours: comparing treatment options to see whether one therapy can match or improve current standard care while maintaining effectiveness.
- Ewing Sarcoma: testing treatment optimization strategies, including approaches aimed at improving survival and balancing benefits with side effects.
- ALK-positive anaplastic large cell lymphoma: evaluating whether a simpler treatment approach can still achieve high cure rates in standard-risk disease.
This research reflects a broader effort in pediatric oncology to improve long-term outcomes, reduce treatment burden where possible, and generate better evidence for children and adolescents with rare cancers.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1GPOH gGmbH2active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1GPOH gGmbH2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Childrens Hospital Of Koblenz
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| International cooperative prospective study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the efficacy of Vinblastine | GPOH gGmbH | Phase III | Recruiting | Feb 2020 | — |
IMP list
lock Showing 1 of 11 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Etoposide | 2 | Unknown | 2019-08-02 | 2022-06-17 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.